These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 23548950)
1. [Paget's disease of bone: new therapeutic strategies]. D'Amore M; Lisi S; Sisto M; De Marino AV Recenti Prog Med; 2013 Mar; 104(3):89-92. PubMed ID: 23548950 [TBL] [Abstract][Full Text] [Related]
3. Paget's disease: a clinical review. Shah M; Shahid F; Chakravarty K Br J Hosp Med (Lond); 2015 Jan; 76(1):25-30. PubMed ID: 25585180 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Paget's disease of bone. Ralston SH Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105 [TBL] [Abstract][Full Text] [Related]
5. [Paget's disease: case report]. Wegierska M; Ignaczak P; Zalewska J; Jeka S Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of Paget's disease]. Kurth AA Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256 [TBL] [Abstract][Full Text] [Related]
7. Etiologic factors in Paget's disease of bone. Reddy SV Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324 [TBL] [Abstract][Full Text] [Related]
8. Paget's disease of bone. Tan A; Ralston SH QJM; 2014 Nov; 107(11):865-9. PubMed ID: 24757095 [TBL] [Abstract][Full Text] [Related]
9. Paget's disease of bone: a review. Colina M; La Corte R; De Leonardis F; Trotta F Rheumatol Int; 2008 Sep; 28(11):1069-75. PubMed ID: 18592244 [TBL] [Abstract][Full Text] [Related]
10. Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease. Grasemann C; Schündeln MM; Hövel M; Schweiger B; Bergmann C; Herrmann R; Wieczorek D; Zabel B; Wieland R; Hauffa BP J Clin Endocrinol Metab; 2013 Aug; 98(8):3121-6. PubMed ID: 23788687 [TBL] [Abstract][Full Text] [Related]
11. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. Abelson A Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Paget's Disease of Bone with Denosumab: Case Report and Literature Review. Reid IR; Sharma S; Kalluru R; Eagleton C Calcif Tissue Int; 2016 Sep; 99(3):322-5. PubMed ID: 27193832 [TBL] [Abstract][Full Text] [Related]
13. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype. Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535 [TBL] [Abstract][Full Text] [Related]
15. [Denosumab as the potent therapeutic agent against Paget's disease of bone]. Hirao M; Hashimoto J Clin Calcium; 2011 Aug; 21(8):1231-8. PubMed ID: 21814030 [TBL] [Abstract][Full Text] [Related]
16. Insights into the pathogenesis of Paget's disease. Roodman GD Ann N Y Acad Sci; 2010 Mar; 1192():176-80. PubMed ID: 20392234 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio. Valverde P Curr Med Chem; 2008; 15(3):284-304. PubMed ID: 18288984 [TBL] [Abstract][Full Text] [Related]
18. Emerging strategies and therapies for treatment of Paget's disease of bone. Michou L; Brown JP Drug Des Devel Ther; 2011; 5():225-39. PubMed ID: 21607019 [TBL] [Abstract][Full Text] [Related]
19. Rare Inherited forms of Paget's Disease and Related Syndromes. Ralston SH; Taylor JP Calcif Tissue Int; 2019 May; 104(5):501-516. PubMed ID: 30756140 [TBL] [Abstract][Full Text] [Related]
20. [[Antiresorptive agents in the treatment of osteoporosis]. Novak S Reumatizam; 2014; 61(2):89-94. PubMed ID: 25427401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]